Teladoc Health, Inc.
NYSE:TDOCMedical - Healthcare Information Services
+$0.20 today
- Market cap
- $1.47B
- Beta
- 2.14
- P/E (TTM)
- -8.1
- EPS (TTM)
- -$0.96
Volume 3.96M
Average 4.68M
TDOC Account Payables
Amounts the company owes suppliers for goods and services received.
Teladoc Health, Inc.NYSE: TDOC
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables falls 13.2% from a year ago
Account payables stood at $45.2M at the end of Q1 FY2026, down 13.2% from a year earlier and down 5.8% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.
Context
- Account payables amounted to 1.6% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Account payables increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps falling in the next quarterly balance sheet after a -13.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 47.97M USD
- Year-over-year change
- +44.8%
- 4-year CAGR
- +0.4%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.97M | +44.8% |
| FY2024 | 2024-12-31 | 33.13M | -24.1% |
| FY2023 | 2023-12-31 | 43.64M | -8.5% |
| FY2022 | 2022-12-31 | 47.69M | +0.9% |
| FY2021 | 2021-12-31 | 47.26M | — |
Account Payables vs competitors
How TDOC compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -13.2% is the 8th highest of 11, against a peer median of +21.7%.
- Account payables amounts to 1.6% of total assets for TDOC, versus a peer median of 2.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $152.05M USD | +8.2% | +4.3% | 21.2% | |
| Mar 2026 | $127.24M USD | +33.8% | +12.8% | 16.1% | |
| Mar 2026 | $58.34M USD | +9.5% | -11.5% | 2.9% | |
| Sep 2026 | $55.22M USD | +46.4% | +15.5% | 3.2% | |
| Mar 2026 | €54.96M EUR | -17.0% | -12.7% | 3.3% | |
| Mar 2026 | $45.2M USD | -13.2% | +0.2% | 1.6% | |
| Apr 2026 | $11.89M USD | +271.1% | +1.9% | 1.8% | |
| Mar 2026 | $8.1M USD | +68.1% | +35.8% | 2.7% | |
| Sep 2026 | $7.95M USD | -13.8% | +6.5% | 1.3% | |
| Sep 2026 | €5.3M EUR | +108.2% | -5.1% | 1.8% | |
| Sep 2026 | $4.46M USD | -27.4% | +11.6% | 0.9% | |
| Peer median (excluding TDOC) | — | +21.7% | +5.4% | 2.8% | |
Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 893.48M | 918.18M | 1.12B | 1.3B | 781.08M |
| Short-term Investments | 2.54M | 0 | 0 | 0 | 0 |
| Net Receivables | 190.12M | 235.65M | 230.06M | 223.96M | 201.66M |
| Inventory | 73.08M | 56.34M | 29.51M | 38.14M | 38.2M |
| Other Current Assets | 27.96M | 12.1M | 40.15M | 36.02M | 2.07M |
| Total Current Assets | 1.23B | 1.29B | 1.49B | 1.66B | 1.09B |
| Property, Plant & Equipment (Net) | 74.01M | 71.47M | 72.09M | 56.58M | 53.09M |
| Goodwill | 14.5B | 1.07B | 1.07B | 283.19M | 283.19M |
| Intangible Assets | 1.91B | 1.84B | 1.68B | 1.43B | 1.3B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 355.6M | 0 | 0 | 242.5M |
| Other Non-current Assets | 20.7M | 78.5M | 80.26M | 81.49M | 137.62M |
| Total Non-current Assets | 16.51B | 3.42B | 2.9B | 1.85B | 2.01B |
| Total Assets | 17.73B | 4.7B | 4.39B | 3.52B | 3.1B |
| Account Payables | 47.26M | 47.69M | 43.64M | 33.13M | 47.97M |
| Short-term Debt | 0 | 13.59M | 0 | 550.72M | 11.04M |
| Tax Payables | 13.06M | 3.82M | 13.55M | 28.11M | 0 |
| Deferred Revenue | 75.57M | 101.83M | 95.66M | 79.3M | 62.31M |
| Other Current Liabilities | 132.21M | 151.28M | 167.26M | 108.69M | 187.17M |
| Total Current Liabilities | 331.01M | 399.77M | 420.62M | 941.54M | 404.74M |
| Long-term Debt | 1.23B | 1.54B | 1.54B | 991.42M | 994.92M |
| Deferred Tax Liabilities | 75.78M | 406.54M | 49.45M | 49.85M | 271.44M |
| Deferred Revenue (Non-current) | 3.83M | 11.95M | 13.62M | 9.79M | 9.14M |
| Other Non-current Liabilities | 10.78M | 1.62M | 1.08M | 720K | 643K |
| Total Non-current Liabilities | 1.36B | 1.99B | 1.65B | 1.08B | 1.31B |
| Total Liabilities | 1.69B | 2.39B | 2.07B | 2.03B | 1.72B |
| Common Stock | 160K | 163K | 167K | 173K | 178K |
| Retained Earnings | (1.42B) | (15.01B) | (15.23B) | (16.23B) | (16.43B) |
| Accumulated OCI | (6.29M) | (42.78M) | (36.99M) | (38.39M) | (34.73M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 16.05B | 2.31B | 2.33B | 1.49B | 1.39B |
| Total Debt | 1.28B | 1.59B | 1.59B | 1.58B | 1.04B |
| Net Debt | 386.65M | 668.74M | 468.6M | 286.29M | 259.08M |
Teladoc Health, Inc.
NYSE:TDOC
Intrinsic Alpha fair value
Locked
Current Price
$8.06
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.